about
An Amino Acid Signature Associated with Obesity Predicts 2-Year Risk of Hypertriglyceridemia in School-Age Children.Diagnosis of inborn errors of metabolism.Temporal development of genetic and metabolic effects of biotin deprivation. A search for the optimum time to study a vitamin deficiency.Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial.Effect of highly active antiretroviral therapy on homocysteine plasma concentrations in HIV-1-infected patients.The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-Mestizo population.Clinical and biochemical characteristics of patients with urea cycle disorders in a developing country.Biotinidase knockout mice show cellular energy deficit and altered carbon metabolism gene expression similar to that of nutritional biotin deprivation: clues for the pathogenesis in the human inherited disorder.Kernicterus in a boy with ornithine transcarbamylase deficiency: A case report.Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits.Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study.Causes of delay in referral of patients with phenylketonuria to a specialized reference centre in Mexico.[COMPARISON OF FREE CARNITINE LEVELS WITH NUTRITIONAL STATUS IN INFANTILE NEPHROPATHYC CISTINOSIS PATIENTS].Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.Biotin deprivation impairs mitochondrial structure and function and has implications for inherited metabolic disorders.Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.[Characterization of inborn errors of intermediary metabolism in mexican patients].Hepatorenal Tyrosinemia in Mexico: A Call to Action.Correspondence on ''experience with hyperphenylalaninemia in a developing country: unusual clinical manifestations and a novel gene mutation''Higher incidence of thyroid agenesis in Mexican newborns with congenital hypothyroidism associated with birth defectsPhenylalanine hydroxylase deficiency in Mexico: genotype-phenotype correlations, BH4 responsiveness and evidence of a founder effect
P50
Q33911961-BF897297-9CA2-4628-BB6F-92D1A8F208C4Q33958397-4A5E0F8F-E4D4-4E6A-8956-5C6A6892C562Q34301825-E4485250-2BC0-43D5-9B2F-4AF5B8BE992DQ35002508-C7450269-9C67-4C46-9120-C19D42FE0D13Q42469539-FF5B6BF1-7818-42B8-ABAF-9172B0A40102Q43142530-17DD5A77-0A6F-4489-87D5-6B864E0A8104Q43212852-5C017657-4978-4041-B086-8EB1F9485A1EQ46313104-7A44A34B-D19B-452A-B08C-A35F43EBB8D7Q48151250-04F1FEAB-E2B6-4B09-91D4-311E4FAD3CA7Q49502660-6D600F15-5EA4-4329-B2D2-E6BDEA5FED8AQ50051454-7E844D6E-EBA9-4F0A-BCB6-9582F1F512F6Q50996422-A87C0B01-87C3-454E-9347-F0C2DE830B77Q51292686-12FBE1E4-C494-4C1A-8A77-FB886119FD90Q52375410-F8F8AE15-9AC5-4CBE-8A70-AB0EC6892581Q52663343-FA448278-8677-4D97-8D7A-63D7AA91B02BQ53438013-0A185F4B-50A9-4B04-879C-0AEF9B939897Q54398479-05DF8A75-E5F3-448E-89E1-C62039211F38Q54665747-0DC5B483-2564-4EFD-9CCB-83772C6CD66EQ83340905-2E50C36D-FC7A-44ED-B824-BED9DDC3868CQ84683651-5EA0536B-C85E-4FB0-B490-413F8826AF91Q88104306-9965827C-03A3-4DBF-AD5C-79CF24491EA0
P50
description
researcher ORCID ID = 0000-0001-8693-8531
@en
wetenschapper
@nl
name
Isabel Ibarra
@ast
Isabel Ibarra
@en
Isabel Ibarra
@es
Isabel Ibarra
@nl
type
label
Isabel Ibarra
@ast
Isabel Ibarra
@en
Isabel Ibarra
@es
Isabel Ibarra
@nl
prefLabel
Isabel Ibarra
@ast
Isabel Ibarra
@en
Isabel Ibarra
@es
Isabel Ibarra
@nl
P1153
6504529819
P21
P31
P496
0000-0001-8693-8531